What is a stock summary page? Click here for an overview.
Business Description
Suzhou Fushilai Pharmaceutical Co Ltd
ISIN : CNE1000058W2
Share Class Description:
SZSE:301258: Class ACompare
Compare
Traded in other countries / regions
301258.China IPO Date
2022-03-29Description
Suzhou Fushilai Pharmaceutical Co Ltd is engaged in the Research and development, production and sales of pharmaceutical intermediates, APIs and raw materials for health care products. The products are mainly used in the fields of medicine, dietary supplements and cosmetics, and have significant effects in anti-oxidation, anti-aging, and blood sugar improvement.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 878.62 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-EBITDA | 0.04 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 9.49 | |||||
| Beneish M-Score | -1.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -14.7 | |||||
| 3-Year EBITDA Growth Rate | -35 | |||||
| 3-Year EPS without NRI Growth Rate | -34.9 | |||||
| 3-Year Book Growth Rate | 24 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 75.11 | |||||
| 9-Day RSI | 69.95 | |||||
| 14-Day RSI | 66.12 | |||||
| 3-1 Month Momentum % | 3.3 | |||||
| 6-1 Month Momentum % | -11.75 | |||||
| 12-1 Month Momentum % | 6.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 11.18 | |||||
| Quick Ratio | 10.16 | |||||
| Cash Ratio | 9.14 | |||||
| Days Inventory | 154.02 | |||||
| Days Sales Outstanding | 66.46 | |||||
| Days Payable | 105.63 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.13 | |||||
| Dividend Payout Ratio | 1.36 | |||||
| Forward Dividend Yield % | 2.13 | |||||
| 5-Year Yield-on-Cost % | 2.13 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | 2.15 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 18.43 | |||||
| Operating Margin % | -0.17 | |||||
| Net Margin % | 7.74 | |||||
| FCF Margin % | -18.14 | |||||
| ROE % | 1.81 | |||||
| ROA % | 1.65 | |||||
| ROIC % | -0.11 | |||||
| 3-Year ROIIC % | -109.78 | |||||
| ROC (Joel Greenblatt) % | 7.96 | |||||
| ROCE % | 2.05 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 76.64 | |||||
| PE Ratio without NRI | 65.91 | |||||
| Shiller PE Ratio | 20.41 | |||||
| PS Ratio | 5.95 | |||||
| PB Ratio | 1.4 | |||||
| Price-to-Tangible-Book | 1.45 | |||||
| Price-to-Operating-Cash-Flow | 102.82 | |||||
| EV-to-EBIT | 31.22 | |||||
| EV-to-EBITDA | 31.22 | |||||
| EV-to-Revenue | 2.81 | |||||
| EV-to-FCF | -15.5 | |||||
| Price-to-GF-Value | 1.07 | |||||
| Price-to-Projected-FCF | 1.3 | |||||
| Price-to-Graham-Number | 2.06 | |||||
| Price-to-Net-Current-Asset-Value | 1.88 | |||||
| Price-to-Net-Cash | 2.37 | |||||
| Earnings Yield (Greenblatt) % | 3.2 | |||||
| FCF Yield % | -3.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Suzhou Fushilai Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 446.261 | ||
| EPS (TTM) (Â¥) | 0.381 | ||
| Beta | 1.31 | ||
| 3-Year Sharpe Ratio | -0.69 | ||
| 3-Year Sortino Ratio | -0.82 | ||
| Volatility % | 38.57 | ||
| 14-Day RSI | 66.12 | ||
| 14-Day ATR (Â¥) | 1.688451 | ||
| 20-Day SMA (Â¥) | 25.054 | ||
| 12-1 Month Momentum % | 6.12 | ||
| 52-Week Range (Â¥) | 19.63 - 43.39 | ||
| Shares Outstanding (Mil) | 91.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Suzhou Fushilai Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Suzhou Fushilai Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Suzhou Fushilai Pharmaceutical Co Ltd Frequently Asked Questions
What is Suzhou Fushilai Pharmaceutical Co Ltd(SZSE:301258)'s stock price today?
The current price of SZSE:301258 is ¥29.20. The 52 week high of SZSE:301258 is ¥43.39 and 52 week low is ¥19.63.
When is next earnings date of Suzhou Fushilai Pharmaceutical Co Ltd(SZSE:301258)?
The next earnings date of Suzhou Fushilai Pharmaceutical Co Ltd(SZSE:301258) is .
Does Suzhou Fushilai Pharmaceutical Co Ltd(SZSE:301258) pay dividends? If so, how much?
The Dividend Yield %  of Suzhou Fushilai Pharmaceutical Co Ltd(SZSE:301258) is 2.13% (As of Today), Highest Dividend Payout Ratio of Suzhou Fushilai Pharmaceutical Co Ltd(SZSE:301258) was 1.36. The lowest was 0.2. And the median was 0.59. The  Forward Dividend Yield % of Suzhou Fushilai Pharmaceutical Co Ltd(SZSE:301258) is 2.13%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers